NDC 0065-0325

EMADINE

Emedastine Difumarate

EMADINE is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Emedastine Difumarate.

Product ID0065-0325_67f002cc-f6d9-4f75-ba05-7021086a21dd
NDC0065-0325
Product TypeHuman Prescription Drug
Proprietary NameEMADINE
Generic NameEmedastine Difumarate
Dosage FormSolution/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date1998-02-15
Marketing CategoryNDA / NDA
Application NumberNDA020706
Labeler NameAlcon Laboratories, Inc.
Substance NameEMEDASTINE DIFUMARATE
Active Ingredient Strength1 mg/mL
Pharm ClassesHistamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0065-0325-05

1 BOTTLE, PLASTIC in 1 CARTON (0065-0325-05) > 5 mL in 1 BOTTLE, PLASTIC
Marketing Start Date1998-02-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0065-0325-05 [00065032505]

EMADINE SOLUTION/ DROPS
Marketing CategoryNDA
Application NumberNDA020706
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1998-02-15

NDC 0065-0325-25 [00065032525]

EMADINE SOLUTION/ DROPS
Marketing CategoryNDA
Application NumberNDA020706
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1998-02-15
Marketing End Date2011-07-13

Drug Details

Active Ingredients

IngredientStrength
EMEDASTINE DIFUMARATE.5 mg/mL

OpenFDA Data

SPL SET ID:98a010d5-4905-4abf-a9d2-c85a07daa23b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 213204
  • 310056
  • Pharmacological Class

    • Histamine H1 Receptor Antagonists [MoA]
    • Histamine-1 Receptor Inhibitor [EPC]

    Trademark Results [EMADINE]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    EMADINE
    EMADINE
    75032887 2231037 Live/Registered
    NOVARTIS AG
    1995-12-15

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.